Press release
Diabetes Care Drugs & Devices Market to hit US$ 244.46 billion by 2033, North America led 39% of global share| Key Players:- F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc.
Diabetes Care Drugs & Devices Market
Diabetes care drugs & devices refer to the pharmaceutical treatments and medical devices designed to help manage, monitor, and control diabetes, a chronic metabolic disorder characterized by high blood glucose levels. These drugs and devices play a crucial role in preventing diabetes-related complications such as cardiovascular diseases, neuropathy, nephropathy, and retinopathy.
The diabetes care drugs and devices market is experiencing significant growth, driven by the increasing prevalence of diabetes worldwide and advancements in diabetes care drugs and devices. Innovations in continuous glucose monitoring systems, insulin pumps, and smart insulin pens have enhanced diabetes management, leading to increased adoption of these devices. Integrating digital health solutions, such as mobile applications and wearable technology, has further propelled market growth.
Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/diabetes-care-drugs-and-devices-market?pratik
Key Industry Development-
✅ June 2025: Tandem Diabetes Care announced compatibility of its t:slim X2 insulin pump with Abbott's FreeStyle Libre 3 Plus 15-day sensor, targeting commercial release in the second half of 2025 to enhance continuous glucose monitoring for Type 1 and Type 2 diabetes patients.
✅ April 2025: Medtronic received FDA clearance for its Simplera Sync sensor, integrating seamlessly with the MiniMed 780G system to eliminate finger-stick calibrations and improve automated insulin delivery accuracy.
✅ April 2025: Abbott integrated data from its FreeStyle Libre CGM systems into Epic's electronic health records via Aura software, streamlining real-time diabetes management and provider workflows.
Recent M&A updates:-
August 2025: Glooko acquired Monarch Medical Technologies, the developer of the EndoTool insulin dosing platform. This move extends Glooko's diabetes care platform from outpatient monitoring into inpatient glycemic management, offering a comprehensive hospital-to-home solution to improve glucose control and reduce complications.
June 2025: Ypsomed announced it is selling Ypsomed Diabetes Care AG, including subsidiaries, patch pump development activities, and related rights, to TecMed, a Swiss company controlled by Willy Michel.
May 2025: Insurer Cha Bio Group assumed operational control of Kakao's "Pasta" blood-glucose management platform in South Korea, acquiring a controlling stake and relieving Kakao of ongoing losses from the business. This deal represents a strategic shift in the management of a significant digital health platform.
March 2025: Sanofi acquired Provention Bio for approximately $2.9 billion. The deal was designed to give Sanofi access to Provention's approved immunotherapy drug Tzield, which is the first and only FDA-approved treatment to delay the onset of Stage 3 Type 1 diabetes.
Report Objectives
The global diabetes care drugs & devices market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.
"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=diabetes-care-drugs-and-devices-market?pratik ((Purchase 2 or more Repots and get 50% Discount)
Market Segment Analysis
→ By Product Type (2025)
Diabetes Drugs - USD 66B (55%): Largest segment driven by insulin, GLP-1, SGLT2, and other chronic therapies.
Diabetes Devices - USD 54B (45%): Strong growth from CGM systems, sensors, and automated insulin delivery devices.
→ By Application (2025)
Type 2 Diabetes - USD 80B (66-67%): Dominant share due to highest global prevalence and broad drug/device use.
Type 1 Diabetes - USD 22B (18%): Smaller population but high per-patient spend on insulin, pumps, and CGM.
Prediabetes - USD 10B (8%): Early-stage therapy, lifestyle programs, and basic monitoring drive revenue.
Gestational Diabetes - USD 8B (7%): Short-term insulin/oral therapy and intensive pregnancy-related monitoring.
Regional insights:-
→ North America: about 39% of global revenue, supported by high prevalence, strong reimbursement, and concentration of key players.
→ Europe: about 27.8%, with mature adoption of advanced therapies and devices and strong regulatory oversight.
→ Asia-Pacific: about 23.4%, but the fastest-growing region due to rising diabetes burden in China, India, Japan and others.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/diabetes-care-drugs-and-devices-market?pratik
Market Drivers
• Rising global diabetes prevalence is increasing demand for advanced drugs and monitoring devices.
• Shift toward early diagnosis boosts adoption of continuous glucose monitors (CGM) and self-monitoring devices.
• Advancements in insulin delivery technologies, including smart pens and automated pumps, improve patient adherence.
• Growing preference for minimally invasive & non-invasive glucose monitoring accelerates device innovation.
• Rise in obesity and sedentary lifestyles continues to fuel diabetes incidence worldwide.
• Government screening programs & reimbursement support enhance accessibility of diabetes treatments and devices.
• Increasing use of digital health and remote monitoring strengthens real-time diabetes management.
• Expanding geriatric population amplifies demand for effective diabetes care solutions.
Major Global Players
→ The major global players in the diabetes care drugs & devices market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Merck & Co., Inc., Novo Nordisk A/S., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc., Insulet Corporation and among others.
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Care Drugs & Devices Market to hit US$ 244.46 billion by 2033, North America led 39% of global share| Key Players:- F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc. here
News-ID: 4310118 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
India Fintech UPI Payments Market to Hit $12.52 Trillion by 2032, Driven by Digi …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" The India fintech & UPI Payments market reached US$ 2.50 Trillion in 2024 and is expected to reach US$ 12.52 Trillion by 2032, growing at a CAGR of 22.3% during the forecast period 2025-2032." Digital-first consumers and instant payment infrastructure are fueling rapid growth in India's UPI-driven fintech ecosystem.
Download your exclusive sample report today: (corporate email gets priority…
Pet Food Ingredients Market Poised for Strong Growth to USD 85.1 Billion by 2031 …
The Global Pet Food Ingredients Market was valued at USD 54.2 billion in 2022 and is projected to reach USD 85.1 billion by 2031, growing at a CAGR of 5.8% during the forecast period 2024-2031. This robust growth is driven by the accelerating global trend of pet humanization, rising pet ownership and adoption, increasing consumer demand for premium and specialized nutrition, and the expansion of ingredient innovations such as organic,…
United States Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drugs Mark …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" The global metabolic dysfunction-associated steatohepatitis (MASH) market size reached US$ 180.1 million in 2024 is expected to reach US$ 929.05 million by 2033, growing at a CAGR of 18.1% during the forecast period 2025-2033." Breakthrough therapies and increasing disease awareness are driving momentum in MASH drug development.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/metabolic-dysfunction-associated-steatohepatitis-mash-drugs-market?Prasad
United…
United States Automotive Wiring Harness Market Gains Momentum with Modular & Sma …
DataM Intelligence unveils its latest report on the "Automotive Wiring Harness Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
